OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
Yuka Tanaka, Maho Murata, Yoshinao Oda, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 355-355
Open Access | Times Cited: 29
Yuka Tanaka, Maho Murata, Yoshinao Oda, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 355-355
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
Xiaojiang Duan, Lei Xia, Zhuochen Zhang, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3395-3407
Open Access | Times Cited: 38
Xiaojiang Duan, Lei Xia, Zhuochen Zhang, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3395-3407
Open Access | Times Cited: 38
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
Subhajit Chatterjee, Saptarshi Sinha, Chanakya Nath Kundu
European Journal of Pharmacology (2021) Vol. 911, pp. 174516-174516
Closed Access | Times Cited: 56
Subhajit Chatterjee, Saptarshi Sinha, Chanakya Nath Kundu
European Journal of Pharmacology (2021) Vol. 911, pp. 174516-174516
Closed Access | Times Cited: 56
Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma
Burak Tekin, John C. Cheville, Loren Herrera Hernandez, et al.
Human Pathology (2023) Vol. 142, pp. 42-50
Closed Access | Times Cited: 15
Burak Tekin, John C. Cheville, Loren Herrera Hernandez, et al.
Human Pathology (2023) Vol. 142, pp. 42-50
Closed Access | Times Cited: 15
A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan
Takamichi Ito, Yuka Tanaka, Dai Ogata, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Takamichi Ito, Yuka Tanaka, Dai Ogata, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nectin‐4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study
Ezra Baraban, Evangelia Vlachou, Sunil Patel, et al.
The Prostate (2025)
Closed Access
Ezra Baraban, Evangelia Vlachou, Sunil Patel, et al.
The Prostate (2025)
Closed Access
The Icarian flight of antibody-drug conjugates: target selection amidst complexity and tackling adverse impacts
Han Liu, Hongye Zeng, Xiaojing Qin, et al.
Protein & Cell (2025)
Open Access
Han Liu, Hongye Zeng, Xiaojing Qin, et al.
Protein & Cell (2025)
Open Access
Nectin‐4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin
Woo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Journal of Cutaneous Pathology (2024) Vol. 51, Iss. 5, pp. 360-367
Closed Access | Times Cited: 4
Woo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Journal of Cutaneous Pathology (2024) Vol. 51, Iss. 5, pp. 360-367
Closed Access | Times Cited: 4
Nectin-4: a Novel Therapeutic Target for Skin Cancers
Hiroki Hashimoto, Yuka Tanaka, Maho Murata, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 4, pp. 578-593
Closed Access | Times Cited: 18
Hiroki Hashimoto, Yuka Tanaka, Maho Murata, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 4, pp. 578-593
Closed Access | Times Cited: 18
NECTIN4‐targeted antibody–drug conjugate is a potential therapeutic option for extramammary Paget disease
Yuka Tanaka, Takamichi Ito, Maho Murata, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 3
Open Access | Times Cited: 3
Yuka Tanaka, Takamichi Ito, Maho Murata, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 3
Open Access | Times Cited: 3
Nectin-4 is widely expressed in head and neck squamous cell carcinoma
Christine Sanders, Jan‐Frederic Lau, Dimo Dietrich, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 1166-1173
Open Access | Times Cited: 17
Christine Sanders, Jan‐Frederic Lau, Dimo Dietrich, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 1166-1173
Open Access | Times Cited: 17
Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma
Yuka Tanaka, Maho Murata, Keiko Tanegashima, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Yuka Tanaka, Maho Murata, Keiko Tanegashima, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development
Wafa Bouleftour, Paul Sargos, Nicolas Magné
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 181-188
Closed Access | Times Cited: 7
Wafa Bouleftour, Paul Sargos, Nicolas Magné
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 181-188
Closed Access | Times Cited: 7
Nail Apparatus Melanoma: Current Management and Future Perspectives
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku‐Ito, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2203-2203
Open Access | Times Cited: 7
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku‐Ito, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2203-2203
Open Access | Times Cited: 7
KS-EMPD-1: a novel cell line of primary extramammary Paget’s disease
Takamichi Ito, Yuka Tanaka, Toshio Ichiki, et al.
Human Cell (2023) Vol. 36, Iss. 5, pp. 1813-1829
Closed Access | Times Cited: 5
Takamichi Ito, Yuka Tanaka, Toshio Ichiki, et al.
Human Cell (2023) Vol. 36, Iss. 5, pp. 1813-1829
Closed Access | Times Cited: 5
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin
Catherine C. Fahey, Caroline A. Nebhan, Sally J. York, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16109-16109
Open Access | Times Cited: 5
Catherine C. Fahey, Caroline A. Nebhan, Sally J. York, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16109-16109
Open Access | Times Cited: 5
Nectins and Nectin-like Molecules in Colorectal Cancer: Role in Diagnostics, Prognostic Values, and Emerging Treatment Options: A Literature Review
Jakub Kobecki, Paweł Gajdzis, Grzegorz Mazur, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3076-3076
Open Access | Times Cited: 8
Jakub Kobecki, Paweł Gajdzis, Grzegorz Mazur, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3076-3076
Open Access | Times Cited: 8
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers
Andrea Vannini, Federico Parenti, Cristina Forghieri, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
Andrea Vannini, Federico Parenti, Cristina Forghieri, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker
Marcel Mayer, Lisa Nachtsheim, Johanna Prinz, et al.
Clinical & Experimental Metastasis (2023) Vol. 40, Iss. 5, pp. 395-405
Open Access | Times Cited: 3
Marcel Mayer, Lisa Nachtsheim, Johanna Prinz, et al.
Clinical & Experimental Metastasis (2023) Vol. 40, Iss. 5, pp. 395-405
Open Access | Times Cited: 3
TROP2 Expression in Sebaceous and Sweat Gland Carcinoma
Takamichi Ito, Hiroki Hashimoto, Yuka Tanaka, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 607-607
Open Access | Times Cited: 5
Takamichi Ito, Hiroki Hashimoto, Yuka Tanaka, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 607-607
Open Access | Times Cited: 5
The prognostic significance of Nectin-2 and Nectin-4 expression in glial tumors
Andrea Dekanić, Emina Babarović, Paola Kučan Brlić, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154416-154416
Closed Access | Times Cited: 2
Andrea Dekanić, Emina Babarović, Paola Kučan Brlić, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154416-154416
Closed Access | Times Cited: 2
Amniotic fluid proteomic analysis identifies IL1RL1, APOE, and NECTIN4 as new biomarkers for preterm birth
Min Li, Mengmei Liu, Ping Chen, et al.
BMC Pregnancy and Childbirth (2024) Vol. 24, Iss. 1
Open Access
Min Li, Mengmei Liu, Ping Chen, et al.
BMC Pregnancy and Childbirth (2024) Vol. 24, Iss. 1
Open Access
Nectin-4: A promising prognostic marker and therapeutic target in cancer
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, et al.
International review of cell and molecular biology (2024), pp. 223-255
Closed Access
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, et al.
International review of cell and molecular biology (2024), pp. 223-255
Closed Access
Keiko Tanegashima, Yuka Tanaka, Takamichi Ito, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 10
Open Access
KS-cSCC-1 and KS-cSCC-2: two novel cutaneous squamous cell carcinoma cell lines established from Japanese patients
Takamichi Ito, Yuka Tanaka, Yumiko Kaku‐Ito, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Takamichi Ito, Yuka Tanaka, Yumiko Kaku‐Ito, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Analysis of Protein–Protein Interactions Identifies NECTIN2 as a Target of N,N-Bis (5-Ethyl-2-hydroxybenzyl) Methylamine for Inhibition of Lung Cancer Metastasis
Sunisa Thongsom, Nithikoon Aksorn, Korrakod Petsri, et al.
Cancer Genomics & Proteomics (2022) Vol. 19, Iss. 5, pp. 624-635
Open Access | Times Cited: 3
Sunisa Thongsom, Nithikoon Aksorn, Korrakod Petsri, et al.
Cancer Genomics & Proteomics (2022) Vol. 19, Iss. 5, pp. 624-635
Open Access | Times Cited: 3
